Results

Total Results: 2,587 records

Showing results for "gender".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
    July 10, 2018 - Gender and sexual orientation if reported* i. Age (M, range if available) j. Race % (by U.S.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
    July 10, 2018 - Gender and sexual orientation if reported* i. Age (M, range if available) j. Race % (by U.S.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - Rates of exposure to biologics, as stratified by age, gender, and race/ethnicity, can be found online
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - Turkey 4; Qatar 1; UK 1 Iran 1 Canada 1; Iran 1; USA 1 N of patients 2,484 1,566 2,001 100 474 Gender
  5. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017820-singh-final-report-2013.pdf
    January 01, 2013 - internal medicine and family medicine; academic and nonacademic practices; and significant racial, gender
  6. hcup-us.ahrq.gov/db/nation/kid/Introduction_to_KID_2000.pdf
    January 01, 2000 - (Continued) Data Element Description (numbers in brackets indicate variable coding) FEMALE Gender
  7. digital.ahrq.gov/sites/default/files/docs/citation/r21hs026565-bull-final-report-2021.pdf
    January 01, 2021 - 4 (12.9) 40-61 14 (45.2) 62-83 10 (32.3) ≥84 3 (9.7) Gender
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/kqRLYDR2eh3gLKbtTjZk__
    November 30, 2017 - Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay.
  9. hcup-us.ahrq.gov/reports/statbriefs/sb101.pdf
    November 09, 2010 - rate for dog bites (110.4 per 100,000) than were females (97.8 per 100,000), while there were no gender
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification
  11. www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening
    November 15, 2022 - blood pressure), 10 STOP-BANG questionnaire (STOP questionnaire plus BMI, age, neck circumference, and gender
  12. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - Baseline calculation allow for estimate of initial baseline risk based on key parameters, including age, gender
  13. cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - Baseline calculation allows for estimate of initial baseline risk based on key parameters, including age, gender
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/DxeDM5ywg2J7SwKmETXfbX
    May 01, 2021 - pressure),10 STOP- BANG questionnaire (STOP questionnaire plus BMI, age, neck cir- cumference, and gender
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - For each AE associated with a particular vaccine, what are risk factors for the AE (including age, gender
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
    September 01, 2008 - Layout 1 Background and Key Questions Although oral antidiabetic agents are used as first-line agents in patients with type 2 diabetes, insulin is required in a significant number of patients at some stage during the management of diabetes to maintain optimal glycemic control. Insulin use has been suggested as a fir…
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
    January 28, 2019 - characteristics (e.g. study design, duration of follow-up), eligibility criteria, study population (e.g. age, gender
  18. S38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
    October 01, 2007 - (%) 37 (17) 42 (20) — *P value based on rank-sum test for ordered characteristics, and �2 test for gender
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - populations, we will record information on sample size; period of enrollment, mean age and age range; sex/gender
  20. digital.ahrq.gov/sites/default/files/docs/publication/r21hs018766-rimmer-final-report-2012.pdf
    January 01, 2012 - after the 12-week intervention exposure period. 6 | P a g e Demographic data, including age, gender